Jagsonpal Pharmaceuticals Limited (BOM:507789)

Jagsonpal Pharmaceuticals Statistics

Total Valuation

BOM:507789 has a market cap or net worth of INR 14.12 billion. The enterprise value is 13.14 billion.

Market Cap	14.12B
Enterprise Value	13.14B

Important Dates

The last earnings date was Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	Sep 12, 2025

Share Statistics

Current Share Class	67.14M
Shares Outstanding	n/a
Shares Change (YoY)	+1.40%
Shares Change (QoQ)	+7.31%
Owned by Insiders (%)	11.34%
Owned by Institutions (%)	1.44%
Float	16.55M

Valuation Ratios

The trailing PE ratio is 32.78.

PE Ratio	32.78
Forward PE	n/a
PS Ratio	4.72
PB Ratio	5.11
P/TBV Ratio	7.13
P/FCF Ratio	30.27
P/OCF Ratio	30.17
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.76, with an EV/FCF ratio of 28.17.

EV / Earnings	30.51
EV / Sales	4.39
EV / EBITDA	18.76
EV / EBIT	21.68
EV / FCF	28.17

Financial Position

The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.03.

Current Ratio	5.06
Quick Ratio	4.36
Debt / Equity	0.03
Debt / EBITDA	0.12
Debt / FCF	0.17
Interest Coverage	58.97

Financial Efficiency

Return on equity (ROE) is 16.69% and return on invested capital (ROIC) is 32.36%.

Return on Equity (ROE)	16.69%
Return on Assets (ROA)	12.74%
Return on Invested Capital (ROIC)	32.36%
Return on Capital Employed (ROCE)	21.02%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.14M
Profits Per Employee	307,949
Employee Count	1,399
Asset Turnover	1.01
Inventory Turnover	6.99

Taxes

In the past 12 months, BOM:507789 has paid 144.36 million in taxes.

Income Tax	144.36M
Effective Tax Rate	25.10%

Stock Price Statistics

The stock price has decreased by -7.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-7.48%
50-Day Moving Average	184.69
200-Day Moving Average	210.12
Relative Strength Index (RSI)	71.56
Average Volume (20 Days)	9,880

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:507789 had revenue of INR 2.99 billion and earned 430.82 million in profits. Earnings per share was 6.31.

Revenue	2.99B
Gross Profit	1.95B
Operating Income	606.25M
Pretax Income	575.18M
Net Income	430.82M
EBITDA	700.69M
EBIT	606.25M
Earnings Per Share (EPS)	6.31

Balance Sheet

The company has 1.06 billion in cash and 81.65 million in debt, with a net cash position of 979.55 million.

Cash & Cash Equivalents	1.06B
Total Debt	81.65M
Net Cash	979.55M
Net Cash Per Share	n/a
Equity (Book Value)	2.76B
Book Value Per Share	39.83
Working Capital	1.15B

Cash Flow

In the last 12 months, operating cash flow was 468.12 million and capital expenditures -1.48 million, giving a free cash flow of 466.64 million.

Operating Cash Flow	468.12M
Capital Expenditures	-1.48M
Depreciation & Amortization	94.44M
Net Borrowing	-12.21M
Free Cash Flow	466.64M
FCF Per Share	n/a

Margins

Gross margin is 65.12%, with operating and profit margins of 20.26% and 14.40%.

Gross Margin	65.12%
Operating Margin	20.26%
Pretax Margin	19.22%
Profit Margin	14.40%
EBITDA Margin	23.42%
EBIT Margin	20.26%
FCF Margin	15.60%

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 1.20%.

Dividend Per Share	2.50
Dividend Yield	1.20%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	1
Payout Ratio	38.67%
Buyback Yield	-1.40%
Shareholder Yield	-0.21%
Earnings Yield	3.05%
FCF Yield	3.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 8, 2025. It was a forward split with a ratio of 2.5.

Last Split Date	Jan 8, 2025
Split Type	Forward
Split Ratio	2.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5